Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard G Presta

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Opinion in Immunology|July 29, 2008
Molecular engineering and design of therapeutic antibodiesLeonard G Presta
Advanced Drug Delivery Reviews|August 15, 2006
Engineering of therapeutic antibodies to minimize immunogenicity and optimize functionLeonard G Presta
The Journal of Allergy and Clinical Immunology|October 8, 2005
Selection, design, and engineering of therapeutic antibodiesLeonard G Presta
Current Pharmaceutical Biotechnology|August 8, 2002
Engineering antibodies for therapyLeonard G Presta
Frontiers in Oncology|November 7, 2022
TCR mimic compounds for pHLA targeting with high potency modalities in oncologyHans-Peter Gerber, Leonard G Presta
Journal of Molecular Biology|June 25, 2002
Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesisFelix F Vajdos, Camellia W Adams, Timothy N Breece, et al.
Blood|February 22, 2014
Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in miceJudith T Murphy, Andre P Burey, Amy M Beebe, et al.
Journal of Immunological Methods|December 18, 2004
Simple quantitative live cell and anti-idiotypic antibody based ELISA for humanized antibody directed to cell surface protein CD20Kyu Hong, Leonard G Presta, Yanmei Lu, et al.
The Journal of Biological Chemistry|May 3, 2002
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicityRobert L Shields, Jadine Lai, Rodney Keck, et al.
International Immunology|November 2, 2006
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune diseaseStefka B Petkova, Shreeram Akilesh, Thomas J Sproule, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Immunology|July 29, 2008
Molecular engineering and design of therapeutic antibodiesLeonard G Presta
Advanced Drug Delivery Reviews|August 15, 2006
Engineering of therapeutic antibodies to minimize immunogenicity and optimize functionLeonard G Presta
The Journal of Allergy and Clinical Immunology|October 8, 2005
Selection, design, and engineering of therapeutic antibodiesLeonard G Presta
Current Pharmaceutical Biotechnology|August 8, 2002
Engineering antibodies for therapyLeonard G Presta
Frontiers in Oncology|November 7, 2022
TCR mimic compounds for pHLA targeting with high potency modalities in oncologyHans-Peter Gerber, Leonard G Presta
Journal of Molecular Biology|June 25, 2002
Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesisFelix F Vajdos, Camellia W Adams, Timothy N Breece, et al.
Blood|February 22, 2014
Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in miceJudith T Murphy, Andre P Burey, Amy M Beebe, et al.
Journal of Immunological Methods|December 18, 2004
Simple quantitative live cell and anti-idiotypic antibody based ELISA for humanized antibody directed to cell surface protein CD20Kyu Hong, Leonard G Presta, Yanmei Lu, et al.
The Journal of Biological Chemistry|May 3, 2002
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicityRobert L Shields, Jadine Lai, Rodney Keck, et al.
International Immunology|November 2, 2006
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune diseaseStefka B Petkova, Shreeram Akilesh, Thomas J Sproule, et al.
Pageof 2